APO Research
Talk to an analyst

APO RESEARCH · REPORT

Andrographolide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Andrographolide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025180 pages

Choose your research edition.

Industry ResearchAndrographolide Tablets Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Andrographolide Tablets Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Andrographolide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Andrographolide Tablets Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Andrographolide Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Andrographolide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Andrographolide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Andrographolide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Andrographolide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Andrographolide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Andrographolide Tablets include Guangdong Wannianqing Pharmaceutical Co., Ltd., Sinopharm Group Yibin Pharmaceutical Co., Ltd., Hainan Huipson Pharmaceutical Biotechnology Co., Ltd., Henan Furentang Pharmaceutical Co., Ltd., Hubei Keyi Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Co., Ltd., Quanzhou Zhongqiao Pharmaceutical Co., Ltd., Wuxi Jiyushanwei Pharmaceutical Co., Ltd. and Chongqing Kerui Pharmaceutical (Group) Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Andrographolide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Andrographolide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Andrographolide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Andrographolide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Andrographolide Tablets Segment by Company

Guangdong Wannianqing Pharmaceutical Co., Ltd.

Sinopharm Group Yibin Pharmaceutical Co., Ltd.

Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.

Henan Furentang Pharmaceutical Co., Ltd.

Hubei Keyi Pharmaceutical Co., Ltd.

Jiangxi Qingfeng Pharmaceutical Co., Ltd.

Quanzhou Zhongqiao Pharmaceutical Co., Ltd.

Wuxi Jiyushanwei Pharmaceutical Co., Ltd.

Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Andrographolide Tablets Segment by Type

Dispersible Tablets

Conventional Tablets

Andrographolide Tablets Segment by Application

Hospital

Clinic

Other

Andrographolide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Andrographolide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Andrographolide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Andrographolide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Andrographolide Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Andrographolide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Andrographolide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Andrographolide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Andrographolide Tablets Industry Trends Table 2. Andrographolide Tablets Industry Drivers Table 3. Andrographolide Tablets Industry Opportunities and Challenges Table 4. Andrographolide Tablets Industry Restraints Table 5. Global Andrographolide Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Andrographolide Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Andrographolide Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Andrographolide Tablets Sales Market Share by Manufacturers Table 9. Global Andrographolide Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Andrographolide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Andrographolide Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Andrographolide Tablets Manufacturers, Product Type & Application Table 13. Global Andrographolide Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Andrographolide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Dispersible Tablets Table 17. Major Manufacturers of Conventional Tablets Table 18. Global Andrographolide Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Andrographolide Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Andrographolide Tablets Sales Market Share by Type (2021-2026) Table 22. Global Andrographolide Tablets Sales Market Share by Type (2027-2032) Table 23. Global Andrographolide Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Andrographolide Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Andrographolide Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Andrographolide Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Andrographolide Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Andrographolide Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Andrographolide Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Andrographolide Tablets Sales Market Share by Application (2021-2026) Table 35. Global Andrographolide Tablets Sales Market Share by Application (2027-2032) Table 36. Global Andrographolide Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Andrographolide Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Andrographolide Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Andrographolide Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Andrographolide Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Andrographolide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Andrographolide Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Andrographolide Tablets Sales Market Share by Region (2021-2026) Table 44. Global Andrographolide Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Andrographolide Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Andrographolide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Andrographolide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Andrographolide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Andrographolide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Andrographolide Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Andrographolide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Andrographolide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Andrographolide Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Andrographolide Tablets Revenue Market Share by Region (2027-2032) Table 63. Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information Table 64. Guangdong Wannianqing Pharmaceutical Co., Ltd. Business Overview Table 65. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 67. Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Development Table 68. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information Table 69. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview Table 70. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 72. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Development Table 73. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information Table 74. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Business Overview Table 75. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio Table 77. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Development Table 78. Henan Furentang Pharmaceutical Co., Ltd. Company Information Table 79. Henan Furentang Pharmaceutical Co., Ltd. Business Overview Table 80. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 82. Henan Furentang Pharmaceutical Co., Ltd. Recent Development Table 83. Hubei Keyi Pharmaceutical Co., Ltd. Company Information Table 84. Hubei Keyi Pharmaceutical Co., Ltd. Business Overview Table 85. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 87. Hubei Keyi Pharmaceutical Co., Ltd. Recent Development Table 88. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information Table 89. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Business Overview Table 90. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 92. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Development Table 93. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information Table 94. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Business Overview Table 95. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 97. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Development Table 98. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information Table 99. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Business Overview Table 100. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 102. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Development Table 103. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information Table 104. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview Table 105. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio Table 107. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Andrographolide Tablets Distributors List Table 111. Andrographolide Tablets Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Andrographolide Tablets Product Image Figure 2. Global Andrographolide Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Andrographolide Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Andrographolide Tablets Sales (2021-2032) & (K Units) Figure 5. Global Andrographolide Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Andrographolide Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Dispersible Tablets Image Figure 9. Conventional Tablets Image Figure 10. Global Andrographolide Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Andrographolide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Andrographolide Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Andrographolide Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Andrographolide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Andrographolide Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Andrographolide Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Andrographolide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Andrographolide Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Andrographolide Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Andrographolide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Andrographolide Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Andrographolide Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Andrographolide Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Andrographolide Tablets Sales Market Share by Country (2021-2032) Figure 39. China Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Andrographolide Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Andrographolide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Andrographolide Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Andrographolide Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Andrographolide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Andrographolide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Andrographolide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Andrographolide Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Andrographolide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Andrographolide Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Andrographolide Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Dispersible Tablets
  • Conventional Tablets
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Guangdong Wannianqing Pharmaceutical Co., Ltd.
  • Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  • Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
  • Henan Furentang Pharmaceutical Co., Ltd.
  • Hubei Keyi Pharmaceutical Co., Ltd.
  • Jiangxi Qingfeng Pharmaceutical Co., Ltd.
  • Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
  • Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
  • Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Andrographolide Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Andrographolide Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Andrographolide Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Andrographolide Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Andrographolide Tablets Market Dynamics
  1. 2.1 Andrographolide Tablets Industry Trends
  2. 2.2 Andrographolide Tablets Industry Drivers
  3. 2.3 Andrographolide Tablets Industry Opportunities and Challenges
  4. 2.4 Andrographolide Tablets Industry Restraints
3 Andrographolide Tablets Market by Manufacturers
  1. 3.1 Global Andrographolide Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Andrographolide Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Andrographolide Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Andrographolide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Andrographolide Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Andrographolide Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Andrographolide Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Andrographolide Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Andrographolide Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Andrographolide Tablets Tier 1, Tier 2, and Tier 3
4 Andrographolide Tablets Market by Type
  1. 4.1 Andrographolide Tablets Type Introduction
  2. 4.1.1 Dispersible Tablets
  3. 4.1.2 Conventional Tablets
  4. 4.2 Global Andrographolide Tablets Sales by Type
  5. 4.2.1 Global Andrographolide Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Andrographolide Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Andrographolide Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Andrographolide Tablets Revenue by Type
  9. 4.3.1 Global Andrographolide Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Andrographolide Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Andrographolide Tablets Revenue Market Share by Type (2021-2032)
5 Andrographolide Tablets Market by Application
  1. 5.1 Andrographolide Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Andrographolide Tablets Sales by Application
  6. 5.2.1 Global Andrographolide Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Andrographolide Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Andrographolide Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Andrographolide Tablets Revenue by Application
  10. 5.3.1 Global Andrographolide Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Andrographolide Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Andrographolide Tablets Revenue Market Share by Application (2021-2032)
6 Global Andrographolide Tablets Sales by Region
  1. 6.1 Global Andrographolide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Andrographolide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Andrographolide Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Andrographolide Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Andrographolide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Andrographolide Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Andrographolide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Andrographolide Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Andrographolide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Andrographolide Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Andrographolide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Andrographolide Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Andrographolide Tablets Revenue by Region
  1. 7.1 Global Andrographolide Tablets Revenue by Region
  2. 7.1.1 Global Andrographolide Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Andrographolide Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Andrographolide Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Andrographolide Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Andrographolide Tablets Revenue (2021-2032)
  8. 7.2.2 North America Andrographolide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Andrographolide Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Andrographolide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Andrographolide Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Andrographolide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Andrographolide Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Andrographolide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Guangdong Wannianqing Pharmaceutical Co., Ltd.
  2. 8.1.1 Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Guangdong Wannianqing Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  6. 8.1.5 Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  8. 8.2.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  12. 8.2.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
  14. 8.3.1 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information
  15. 8.3.2 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Business Overview
  16. 8.3.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio
  18. 8.3.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Developments
  19. 8.4 Henan Furentang Pharmaceutical Co., Ltd.
  20. 8.4.1 Henan Furentang Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Henan Furentang Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  24. 8.4.5 Henan Furentang Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Hubei Keyi Pharmaceutical Co., Ltd.
  26. 8.5.1 Hubei Keyi Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Hubei Keyi Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  30. 8.5.5 Hubei Keyi Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Jiangxi Qingfeng Pharmaceutical Co., Ltd.
  32. 8.6.1 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  36. 8.6.5 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
  38. 8.7.1 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  42. 8.7.5 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
  44. 8.8.1 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  48. 8.8.5 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
  50. 8.9.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
  51. 8.9.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview
  52. 8.9.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio
  54. 8.9.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Andrographolide Tablets Value Chain Analysis
  2. 9.1.1 Andrographolide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Andrographolide Tablets Production Mode & Process
  6. 9.2 Andrographolide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Andrographolide Tablets Distributors
  9. 9.2.3 Andrographolide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst